Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
J Clin Apher
; 30(1): 50-4, 2015 Feb.
Article
en En
| MEDLINE
| ID: mdl-25042026
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Intercambio Plasmático
/
Púrpura Trombocitopénica Trombótica
/
Factor VIII
/
Proteínas ADAM
/
Rituximab
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
J Clin Apher
Año:
2015
Tipo del documento:
Article